李氏大藥廠：2024年年報.pdf

1、2024ANNUAL REPORT(incorporated in the Cayman Islands with limited liability 於開曼群島註冊成立之有限公司)(Stock Code 股份代號:950)年 報*For identification purpose only 僅供識別CONTENTS目 錄Corporate Information2公司資料Corporate Profile4公司簡介Financial Highlights7財務概要Five-Year Financial Summary9五年財務摘要Chairmans Statement10主席報告Manag

2、ement Discussion and Analysis13管理層討論及分析Directors and Key Personnel Profiles24董事及主要人員履歷Report of the Directors32董事會報告Corporate Governance Report55企業管治報告Independent Auditors Report66獨立核數師報告Consolidated Statement of Profit or Loss75綜合損益表Consolidated Statement of Profit or Loss and Other Comprehensive I

3、ncome76綜合損益及其他全面收益表Consolidated Statement of Financial Position77綜合財務狀況表Consolidated Statement of Changes in Equity79綜合權益變動表Consolidated Statement of Cash Flows81綜合現金流量表Notes to the Consolidated Financial Statements83綜合財務報表附註Definition 230 釋義Lees Pharmaceutical Holdings Limited 李氏大藥廠控股有限公司2Corporate

4、 Information公司資料BOARD OF DIRECTORSExecutive DirectorsMs.Lee Siu Fong(Chairman)Ms.Leelalertsuphakun Wanee(Managing Director)Non-executive DirectorsDr.Li XiaoyiMr.James Charles GaleMr.Huang Zuie-Chin(appointed with effect from 2 July 2024)Independent Non-executive DirectorsDr.Chan Yau Ching,BobMs.Chea

5、ng Yee Wah,EvaDr.Tsim Wah Keung,KarlCOMPANY SECRETARYMr.Chow Yiu MingAUDIT COMMITTEEDr.Chan Yau Ching,Bob(Chairman)Ms.Cheang Yee Wah,EvaDr.Tsim Wah Keung,KarlREMUNERATION COMMITTEEDr.Tsim Wah Keung,Karl(Chairman)Ms.Leelalertsuphakun WaneeDr.Chan Yau Ching,BobNOMINATION COMMITTEEMs.Lee Siu Fong(Chair

6、man)Dr.Chan Yau Ching,BobDr.Tsim Wah Keung,KarlMANAGEMENT COMMITTEEMs.Leelalertsuphakun Wanee(Chairman)Ms.Lee Siu Fong董事會執行董事李小芳女士（主席）李燁妮女士（董事總經理）非執行董事李小羿博士James Charles Gale先生黃瑞瑨先生（任命自二零二四年七月二日起生效）獨立非執行董事陳友正博士蔣綺華女士詹華強博士公司秘書鄒耀明先生審核委員會陳友正博士（主席）蔣綺華女士詹華強博士薪酬委員會詹華強博士（主席）李燁妮女士陳友正博士提名委員會李小芳女士（主席）陳友正博士詹華強博